• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性手术后延迟辅助化疗是否会影响结直肠癌患者的生存?一项荟萃分析。

Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.

机构信息

AP-HP, Department of Oncology, Avicenne Hospital, 125 route de Stalingrad, 93009 Bobigny, France.

出版信息

Eur J Cancer. 2010 Apr;46(6):1049-55. doi: 10.1016/j.ejca.2010.01.020.

DOI:10.1016/j.ejca.2010.01.020
PMID:20138505
Abstract

BACKGROUND

In stage III colorectal cancer (CRC), adjuvant chemotherapy (CT) is usually prescribed within two months after curative surgery. Whether or not delaying initiation of CT affects survival is still debated.

MATERIAL AND METHODS

We performed a meta-analysis (MA) of all published studies (full papers or abstracts) comparing delayed CT with standard care. Studies were obtained from a PubMed query (keywords: CRC, adjuvant treatment, delay of CT), a review (Chau et al., 2006), cross-checking references and abstracts from the proceedings of ASCO, ASCO GI and WCGI annual meetings. We chose a cutoff delay of 8 weeks. Risk Ratios (RRs) were calculated from the recorded events (deaths, relapses). We used EasyMA software (fixed-effect model).

RESULTS

Fourteen studies (including four abstracts) were identified (17,645 patients; 5,952 males, 5,151 females, mean age 70 years). Of these, three could not be statistically analysed and three used another cutoff (4, 5 or 6 weeks), leaving 8 studies for main MA (13,158 patients; 3,932 males, 3,644 females, 5,942 missing data; 5,576 colon cancers, 6,677 rectal, 1,265 missing data). Delaying CT more than 8 weeks was associated to worse Overall Survival (OS) (RR: 1.20; 95% Confidence Interval (CI) 1.15-1.26). In the MA including all studies whatever their cutoff, longer delay was similarly associated to a worse OS but not a worse Relapse-Free Survival (RFS) (five studies).

CONCLUSION

Adjuvant chemotherapy should be started within 8 weeks after surgery. Delaying the initiation of adjuvant CT for more than 8 weeks after surgery significantly decreased OS but not RFS. This discrepancy might be due to factors not directly related to cancer (post-operative complications, social status) or to a more accurate appraisal of death.

摘要

背景

在 III 期结直肠癌(CRC)中,辅助化疗(CT)通常在根治性手术后两个月内进行。延迟 CT 起始时间是否会影响生存仍存在争议。

材料和方法

我们对所有已发表的研究(全文或摘要)进行了荟萃分析(MA),比较了延迟 CT 与标准治疗。研究通过 PubMed 查询(关键词:CRC、辅助治疗、CT 延迟)、综述(Chau 等人,2006 年)、交叉检查 ASCO、ASCO GI 和 WCGI 年会的参考文献和摘要获得。我们选择 8 周的截止延迟。风险比(RR)是根据记录的事件(死亡、复发)计算得出的。我们使用 EasyMA 软件(固定效应模型)进行分析。

结果

确定了 14 项研究(包括 4 项摘要)(17645 名患者;5952 名男性,5151 名女性,平均年龄 70 岁)。其中,3 项研究无法进行统计学分析,3 项研究使用了另一个截止值(4、5 或 6 周),因此,8 项研究纳入主要 MA(13158 名患者;3932 名男性,3644 名女性,5942 项缺失数据;5576 例结肠癌,6677 例直肠癌,1265 项缺失数据)。延迟 CT 超过 8 周与总生存(OS)更差相关(RR:1.20;95%置信区间(CI)1.15-1.26)。在包括所有研究的 MA 中,无论其截止值如何,更长的延迟同样与 OS 更差相关,但与无复发生存率(RFS)无差异(5 项研究)。

结论

辅助化疗应在手术后 8 周内开始。手术后 8 周后延迟启动辅助 CT 显著降低了 OS,但未降低 RFS。这种差异可能是由于与癌症无关的因素(术后并发症、社会地位)或对死亡的更准确评估所致。

相似文献

1
Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.根治性手术后延迟辅助化疗是否会影响结直肠癌患者的生存?一项荟萃分析。
Eur J Cancer. 2010 Apr;46(6):1049-55. doi: 10.1016/j.ejca.2010.01.020.
2
Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.早期乳腺癌从根治性手术到辅助化疗开始的时间对生存的影响。
J Clin Oncol. 2006 Oct 20;24(30):4888-94. doi: 10.1200/JCO.2005.01.6089. Epub 2006 Oct 2.
3
Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.辅助化疗对III期结直肠癌患者的临床影响:左旋亚叶酸/5-氟尿嘧啶化疗作为改良的RPMI方案是生存的独立预后因素。
Anticancer Res. 2006 Mar-Apr;26(2B):1425-32.
4
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.
5
Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.根治性切除的非小细胞肺癌辅助化疗:对311例连续治疗患者的回顾性分析
Lung Cancer. 2005 Jan;47(1):93-101. doi: 10.1016/j.lungcan.2004.06.008.
6
Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).辅助化疗开始时间对乳腺癌生存的影响:西班牙乳腺癌研究小组(GEICAM)的一项阴性结果研究
Breast Cancer Res Treat. 2007 Jan;101(2):215-23. doi: 10.1007/s10549-006-9282-0. Epub 2006 Jul 6.
7
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.完全切除胃癌的辅助化疗:由GOIRC开展的一项随机III期试验
J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11.
8
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.腋窝淋巴结阴性、雌激素受体阴性乳腺癌的治疗:国家外科辅助乳腺和肠道项目临床试验的最新结果
J Natl Cancer Inst. 2004 Dec 15;96(24):1823-31. doi: 10.1093/jnci/djh338.
9
[Recent advances is surgical adjuvant chemotherapy for colorectal cancer].[结直肠癌外科辅助化疗的最新进展]
Gan To Kagaku Ryoho. 2000 Dec;27(14):2201-8.
10
Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.II-III期可切除直肠癌患者术后辅助放疗与术后序贯放疗联合5-氟尿嘧啶和左旋咪唑的随机临床试验:最终报告
J Surg Oncol. 2003 Jul;83(3):140-6. doi: 10.1002/jso.10261.

引用本文的文献

1
Postoperative C-reactive protein to albumin ratio as early predictive factors for prolonged postoperative hospital stay after highly advanced hepatobiliary-pancreatic surgery: a single-center retrospective study.术后C反应蛋白与白蛋白比值作为高度复杂肝胆胰手术后延长住院时间的早期预测因素:一项单中心回顾性研究
BMC Surg. 2025 Aug 23;25(1):387. doi: 10.1186/s12893-025-03112-3.
2
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset.pT4N0结肠癌的预后影响及临床管理:来自大型多中心国际真实世界数据集的数据
ESMO Open. 2025 Jul 15;10(8):105496. doi: 10.1016/j.esmoop.2025.105496.
3
Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study.
新辅助治疗的胃癌患者术后化疗时机与预后:一项多中心真实世界队列研究
Ann Med. 2025 Dec;57(1):2500690. doi: 10.1080/07853890.2025.2500690. Epub 2025 May 7.
4
Short- and long-term outcomes of minimally invasive vs. open pelvic exenteration in rectal tumours: a focused meta-analysis.直肠肿瘤微创与开放盆腔脏器清除术的短期和长期结局:一项聚焦的荟萃分析。
Int J Colorectal Dis. 2025 Apr 3;40(1):86. doi: 10.1007/s00384-025-04876-z.
5
The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands.辅助化疗在直肠癌中的作用:一项来自荷兰的全国性队列研究。
Colorectal Dis. 2025 Mar;27(3):e70054. doi: 10.1111/codi.70054.
6
The impact of postoperative recurrent postoperative ileus on the prognosis of colorectal cancer: a propensity score matched study.术后复发性肠梗阻对结直肠癌预后的影响:一项倾向评分匹配研究
Updates Surg. 2025 Mar 9. doi: 10.1007/s13304-025-02142-z.
7
Socioeconomic and geographic variation in adjuvant chemotherapy among elderly patients with stage III colon cancer in Norway - a national register-based cohort study.挪威III期结肠癌老年患者辅助化疗的社会经济和地理差异——一项基于全国登记的队列研究
Res Health Serv Reg. 2024 Dec 17;3(1):21. doi: 10.1007/s43999-024-00057-7.
8
Predicting disease-free survival in locally advanced rectal cancer using a prognostic model based on pretreatment b-value threshold map and postoperative pathologic features.使用基于术前b值阈值图和术后病理特征的预后模型预测局部晚期直肠癌的无病生存期。
Jpn J Radiol. 2025 Feb;43(2):236-246. doi: 10.1007/s11604-024-01674-5. Epub 2024 Oct 21.
9
Racial comparisons in treatment of rectal adenocarcinoma and survival in the military health system.在军队卫生系统中,直肠癌治疗和生存的种族比较。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae074.
10
The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful predictor of postoperative complications in patients with a colonic stent for obstructive colorectal cancer: a Japanese multicenter study.C反应蛋白-白蛋白-淋巴细胞(CALLY)指数是结肠支架置入治疗阻塞性结直肠癌患者术后并发症的有效预测指标:一项日本多中心研究。
Surg Today. 2025 Apr;55(4):502-509. doi: 10.1007/s00595-024-02924-9. Epub 2024 Aug 23.